SCTX
SCTX
US8110331092
Scribe Therapeutics Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 51.174.000 27.413.000
86.7%
Cost of Revenue -- --
--
Gross Profit -- --
--
77.244.000 70.242.000
10.0%
Operating Income -26.070.000 -42.829.000
39.1%
Pretax Income -23.610.000 -37.561.000
37.1%
Net Income Common Stockholders -21.808.000 -47.786.000
54.4%
-- --
--
-- --
--
ende